{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-23-000037","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.440534+00:00","generated_at":"2026-06-19T22:20:41.099723+00:00","sec_items":["1.01","2.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifecore Biomedical sells avocado products business for $17.5M cash","bullets":["Purchase price of $17.5M in cash, subject to post-closing adjustments including net working capital.","Sale includes Yucatan and Cabo Fresh brands and manufacturing facility in Guanajuato, Mexico.","Net proceeds used to repay borrowings under existing credit agreements.","Lifecore retains only O Olive from former Curation Foods segment; continues to grow core business.","Transition services agreement with buyer for up to three months following closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-23-000037","json":"https://secwatch.observer/filing/0001005286-23-000037.json","markdown":"https://secwatch.observer/filing/0001005286-23-000037.md","text":"https://secwatch.observer/filing/0001005286-23-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/lndc-20230207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:20:41.099723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45f19847934988df1be424d5b79ffe3c590da526","claim":"LIFECORE BIOMEDICAL, INC. DE completed a disposition involving Yucatan Acquisition Holdings LLC for $17.5 million in cash (closed 2023-02-07).","evidence_excerpt":"executed by the Parties on February 7, 2023 (the “Securities Purchase Agreement”). Pursuant to the Securities Purchase Agreement, Buyer acquired Yucatan for a purchase price of $17.5 million in cash, subject to certain post-closing adjustments, including net working capital, at closing. Following the Yucatan Disposition, the Company continues to grow its Lifecore","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Yucatan Acquisition Holdings LLC"},{"label":"Consideration","value":"$17.5 million in cash"},{"label":"Closing","value":"2023-02-07"}],"fact_type":"ma_transaction"},{"claim_id":"208506b7830418a0b8455d1cf8762f7f9289be54","claim":"LIFECORE BIOMEDICAL, INC. DE entered into Securities Purchase Agreement with Yucatan Acquisition Holdings LLC, Yucatan Foods, LLC, Camden Fruit Corp. (effective 2023-02-07).","evidence_excerpt":"Securities Purchase Agreement, dated February 7, 2023, by and among Lifecore Biomedical, Inc., Yucatan Foods, LLC, Camden Fruit Corp., and Yucatan Acquisition Holdings LLC.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528623000037/0001005286-23-000037-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Yucatan Acquisition Holdings LLC, Yucatan Foods, LLC, Camden Fruit Corp."},{"label":"Effective","value":"2023-02-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}